tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Celldex Therapeutics Inc

CLDX
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
37.830USD
-1.150-2.95%
์‹œ์žฅ ์šด์˜ ์‹œ๊ฐ„ย 09/18, 14:30๏ผˆET๏ผ‰
2.97B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Celldex Therapeutics Inc

37.830
-1.150-2.95%
๊ฐœ์š”
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

CLDX ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Celldex Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
2.97B
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-8.87
์ฃผ๋‹น์ˆœ์ด์ต
-4.27
์ˆ˜์ต
1.54M
์ˆœ์ด์ต
-157.86M
ROE
-48.94%
ROA
-45.36%

Celldex Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 6, 2026
EPS / ์˜ˆ์ƒ
-0.94/-1.06
์ˆ˜์ต / ์˜ˆ์ƒ
22.00K/954.44K

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-10.76%-0.94
-45.86%-1.18
-72.36%-1.22
-58.87%-1.01
-57.03%-0.85
-45.42%-0.81
14.69%-0.71
21.52%-0.64
15.89%-0.54
10.38%-0.56
-48.01%-0.83
---0.81
---0.65
---0.62
---0.56
----
----
----
----
----
์ˆ˜์ต
-96.99%22.00K
-97.84%15.00K
-89.70%121.00K
-100.00%0.00
-70.78%730.00K
345.51%695.00K
-71.56%1.18M
110.35%3.19M
832.09%2.50M
-83.87%156.00K
156.11%4.13M
272.73%1.52M
64.42%268.00K
455.75%967.00K
382.93%1.61M
166.01%407.00K
-95.32%163.00K
-74.60%174.00K
-91.18%334.00K
-77.10%153.00K
์ˆœ์ด์ต
-29.86%-73.50M
-46.27%-78.69M
-72.68%-81.32M
-59.17%-67.04M
-57.92%-56.60M
-63.97%-53.80M
-8.74%-47.09M
-10.09%-42.12M
-17.51%-35.84M
-11.74%-32.81M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.50M
-27.38%-29.36M
-31.46%-26.49M
-30.96%-26.78M
-169.23%-36.00M
-39.38%-23.05M
8.00%-20.15M
-43.79%-20.45M
์ˆœ์ด์ต๋ฅ 
-4209.12%-334104.55%
-6676.97%-524566.67%
-1576.82%-67204.13%
----
-440.37%-7753.42%
63.19%-7740.43%
-282.31%-4007.83%
47.66%-1319.99%
87.39%-1434.83%
-592.65%-21030.77%
36.16%-1048.32%
---2522.08%
---11381.34%
---3036.30%
---1642.10%
----
----
----
----
----
์ด ์ด์ต๋ฅ 
0.00%100.00%
0.00%100.00%
0.00%100.00%
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
----
--0.00%
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
-96.99%22.00K
-97.84%15.00K
-89.70%121.00K
-100.00%0.00
-70.78%730.00K
345.51%695.00K
-71.56%1.18M
110.35%3.19M
832.09%2.50M
-83.87%156.00K
156.11%4.13M
272.73%1.52M
64.42%268.00K
455.75%967.00K
382.93%1.61M
166.01%407.00K
-95.32%163.00K
-74.60%174.00K
-91.18%334.00K
-77.10%153.00K
์˜์—… ์ด์ต
-26.26%-80.62M
-34.58%-84.44M
-55.56%-87.15M
-41.23%-73.62M
-37.87%-63.86M
-54.50%-62.74M
-59.50%-56.03M
-26.40%-52.13M
-39.49%-46.32M
-25.06%-40.61M
-25.97%-35.13M
-48.90%-41.24M
-19.78%-33.20M
-36.47%-32.47M
-35.46%-27.89M
-44.06%-27.70M
-110.30%-27.72M
-47.27%-23.79M
-100.57%-20.59M
-40.53%-19.23M
์ˆœ์ด์ต
-29.86%-73.50M
-46.27%-78.69M
-72.68%-81.32M
-59.17%-67.04M
-57.92%-56.60M
-63.97%-53.80M
-8.74%-47.09M
-10.09%-42.12M
-17.51%-35.84M
-11.74%-32.81M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.50M
-27.38%-29.36M
-31.46%-26.49M
-30.96%-26.78M
-169.23%-36.00M
-39.38%-23.05M
8.00%-20.15M
-43.79%-20.45M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
11.80%724.93M
-33.81%459.22M
-28.44%534.66M
-22.41%604.34M
-20.14%648.40M
-16.95%693.76M
73.08%747.16M
216.69%778.84M
206.61%811.98M
188.44%835.32M
35.88%431.69M
-26.50%245.93M
-28.03%264.82M
-25.88%289.60M
-22.67%317.69M
-21.56%334.60M
119.55%367.98M
115.26%390.70M
107.66%410.84M
110.20%426.56M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
86.04%61.33M
60.76%51.47M
29.09%50.99M
44.78%46.47M
19.18%32.96M
21.78%32.02M
26.91%39.50M
15.29%32.09M
76.77%27.66M
72.75%26.29M
67.25%31.13M
70.91%27.84M
-47.76%15.65M
4.53%15.22M
12.60%18.61M
14.89%16.29M
106.72%29.95M
-14.24%14.56M
16.35%16.53M
16.20%14.18M
์ด ์ž์‚ฐ
12.99%782.35M
-30.86%511.25M
-26.42%582.98M
-21.23%648.44M
-18.12%692.41M
-14.89%739.47M
70.17%792.34M
193.72%823.18M
182.51%845.59M
167.73%868.85M
32.00%465.63M
-24.10%280.26M
-25.72%299.31M
-23.47%324.52M
-20.67%352.74M
-19.77%369.23M
97.00%402.96M
93.57%424.04M
88.54%444.65M
79.93%460.20M
๋ถ€์ฑ„ ์ด๊ณ„
83.20%67.78M
50.80%55.03M
23.12%55.82M
34.35%50.08M
15.89%37.00M
20.69%36.49M
24.36%45.34M
11.14%37.27M
46.63%31.93M
38.82%30.23M
37.41%36.46M
40.86%33.54M
-42.50%21.77M
-16.04%21.78M
5.37%26.53M
1.37%23.81M
70.05%37.87M
4.18%25.94M
-4.92%25.18M
-8.94%23.49M
์ž๋ณธ ์ด๊ณ„
9.03%714.56M
-35.10%456.23M
-29.43%527.16M
-23.86%598.36M
-19.45%655.41M
-16.17%702.98M
74.06%747.00M
218.54%785.90M
193.17%813.66M
177.01%838.61M
31.57%429.17M
-28.57%246.72M
-23.98%277.54M
-23.95%302.74M
-22.24%326.20M
-20.91%345.42M
100.29%365.09M
105.03%398.10M
100.36%419.48M
89.90%436.71M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-30.46%-57.41M
-20.63%-65.59M
-96.88%-63.94M
12.12%-48.63M
-50.05%-44.01M
-33.80%-54.37M
0.18%-32.48M
-191.35%-55.34M
-7.84%-29.33M
-42.25%-40.64M
-49.49%-32.53M
46.03%-18.99M
-22.26%-27.20M
-16.45%-28.57M
-49.85%-21.76M
-114.95%-35.19M
-86.45%-22.24M
-35.67%-24.53M
-178.70%-14.52M
-38.03%-16.37M
์ˆœํˆฌ์ž
-612.58%-255.52M
67.91%72.12M
130.49%55.42M
27.41%60.85M
206.69%49.85M
113.63%42.95M
114.05%24.05M
310.08%47.76M
-4114.00%-46.72M
-699.61%-315.21M
-648.36%-171.16M
-49.51%11.65M
-95.40%1.16M
406.45%52.57M
264.76%31.21M
110.17%23.07M
281.72%25.28M
-76.13%10.38M
-161.40%-18.94M
-433.54%-226.79M
์ˆœ์žฌ๋ฌดํ™œ๋™
515228.57%324.66M
61.88%327.00K
249.48%1.35M
-37.53%774.00K
-98.30%63.00K
-99.95%202.00K
-99.82%386.00K
382.10%1.24M
2690.98%3.71M
62740.35%436.11M
15482.37%217.37M
-88.86%257.00K
87.32%133.00K
128.29%694.00K
227.46%1.40M
-99.15%2.31M
384.00%71.00K
310.81%304.00K
868.18%426.00K
5954.26%271.90M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Celldex Therapeutics Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 1.54M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 7.02M์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 534.66M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -28.44์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Celldex Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 582.98M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -26.42์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Celldex Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 55.82M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 23.12์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Celldex Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 527.16M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -29.43์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Celldex Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -287.37M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -47.31์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Celldex Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” 209.07M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 172.06์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Celldex Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 2.39M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -99.46์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -3.90์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -58.91์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -258.76M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -63.91์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -16748.03์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -644.77์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -40.62์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -51.31์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -37.63์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -49.93์ž…๋‹ˆ๋‹ค.

Celldex Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Celldex Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -287.37M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -47.31์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ